SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) will announce corporate and financialresults for the third quarter of 2017 on Monday, November 13th after the market closes. Following the announcement, Orexigen will provide a business update and discuss the financial results in a live webcast
The live call may be accessed by phone by calling (800) 708-4539 (domestic) or (847) 619-6396 (international), participant code 45886353. The webcast can be accessed live on the "Investors" section of the Orexigen web site at www.orexigen.com, and will be archived for 14 days following the call.
Orexigen Contact:Jason KeyesChief Financial OfficerOrexigen Therapeutics, Inc. +email@example.com
Media Contact: Erika HackmannY&Rfirstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-and-discuss-third-quarter-2017-financial-results-on-november-13-2017-300546934.html
SOURCE Orexigen Therapeutics, Inc.
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All